Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

Author:

Bartlett Nancy L.1,Smith Mitchell R.2ORCID,Siddiqi Tanya3,Advani Ranjana H.4,O’Connor Owen A.5,Sharman Jeff P.6,Feldman Tatyana7,Savage Kerry J.8,Shustov Andrei R.9,Diefenbach Catherine S.10,Oki Yasuhiro11,Palanca-Wessels Maria Corinna12,Uttarwar Mayur13,Li Martha14,Yang Jing15,Jacobsen Eric D.16

Affiliation:

1. Department of Medicine, Oncology Division, Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA;

2. Hematology and Oncology, The Cleveland Clinic, Cleveland, OH, USA;

3. Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA;

4. Medicine ? Oncology, Stanford University Medical Center, Stanford, CA, USA;

5. Medicine and Experimental Therapeutics, Columbia University Medical Center/New York Presbyterian Hospital, New York, NY, USA;

6. Medical Oncology ? Hematology Research, Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR, USA;

7. Oncology ? Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, USA;

8. Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;

9. Division of Hematology, Seattle Cancer Care Alliance/University of Washington Medical Center, Seattle, WA, USA;

10. Department of Medicine, New York University Langone Medical Center, New York, NY, USA;

11. Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA;

12. Clinical Development, Seattle Genetics, Inc., Bothell, WA, USA;

13. Biostatistics, Seattle Genetics, Inc., Bothell, MA, USA;

14. Diagnostics & Biomarkers, Seattle Genetics, Inc., Bothell, MA, USA;

15. Clinical Pharmacology, Seattle Genetics, Inc., Bothell, MA, USA;

16. Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3